Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Perindopril × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Women With Breast Cancer 1 Heart Failure 1 Colorectal Neoplasms 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Trastuzumab 529 Paclitaxel 482 Cyclophosphamide 472 Docetaxel 418 Capecitabine 354 Letrozole 315 Fulvestrant 272 Doxorubicin 248 Tamoxifen 232 Carboplatin 230 Anastrozole 201 Radiotherapy 195 exemestane 188 Epirubicin 172 Bevacizumab 166 palbociclib 153 Lapatinib 148 pertuzumab 144 Vinorelbine 143 Gemcitabine 139 pembrolizumab 138 Surveys and Questionnaires 119 Magnetic Resonance Spectroscopy 113 Exercise 113 eribulin 104 Fluorouracil 102 Albumin-Bound Paclitaxel 100 Blood Specimen Collection 98 130-nm albumin-bound paclitaxel 91 Everolimus 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡